Thomas J Moore

Summary

Affiliation: Institute for Safe Medication Practices
Country: USA

Publications

  1. pmc Suicidal behavior and depression in smoking cessation treatments
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia, United States of America
    PLoS ONE 6:e27016. 2011
  2. doi request reprint Thoughts and acts of aggression/violence toward others reported in association with varenicline
    Thomas J Moore
    Institute for Safe Medication Practices, Horsham, PA, USA
    Ann Pharmacother 44:1389-94. 2010
  3. ncbi request reprint Reported adverse event cases of methemoglobinemia associated with benzocaine products
    Thomas J Moore
    Institute for Safe Medication Practices, Huntingdon Valley, PA, USA
    Arch Intern Med 164:1192-6. 2004
  4. ncbi request reprint Reported medication errors associated with methotrexate
    Thomas J Moore
    Drug Safety and Policy, Institute for Safe Medication Practices, Huntingdon Valley, PA 19006, USA
    Am J Health Syst Pharm 61:1380-4. 2004
  5. ncbi request reprint Serious adverse drug events reported to the Food and Drug Administration, 1998-2005
    Thomas J Moore
    Institute for Safe Medication Practices, 1800 Byberry Rd, Ste 810, Huntingdon Valley, PA 19006, USA
    Arch Intern Med 167:1752-9. 2007
  6. pmc Prescription drugs associated with reports of violence towards others
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia, United States of America
    PLoS ONE 5:e15337. 2010
  7. doi request reprint Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia2Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services, Washington, DC
    JAMA Intern Med 174:90-5. 2014
  8. doi request reprint Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR)
    Thomas J Moore
    The Institute for Safe Medication Practices, Horsham, Pennsylvania, USA
    Semin Thromb Hemost 38:905-7. 2012
  9. pmc Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration
    Irving Kirsch
    Department of Psychology, University of Hull, Hull, United Kingdom
    PLoS Med 5:e45. 2008
  10. ncbi request reprint Reported adverse drug events in infants and children under 2 years of age
    Thomas J Moore
    Center for Health Services Research and Policy, George Washington University School of Public Health and Health Services, Washington, DC 20006, USA
    Pediatrics 110:e53. 2002

Collaborators

Detail Information

Publications10

  1. pmc Suicidal behavior and depression in smoking cessation treatments
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia, United States of America
    PLoS ONE 6:e27016. 2011
    ..However, some epidemiological studies report an increased risk in smoking or smoking cessation independent of treatment, and differences between drugs are unknown...
  2. doi request reprint Thoughts and acts of aggression/violence toward others reported in association with varenicline
    Thomas J Moore
    Institute for Safe Medication Practices, Horsham, PA, USA
    Ann Pharmacother 44:1389-94. 2010
    ..Thoughts and acts of aggression/violence toward others have been reported in postmarketing surveillance of varenicline, an aid to smoking cessation...
  3. ncbi request reprint Reported adverse event cases of methemoglobinemia associated with benzocaine products
    Thomas J Moore
    Institute for Safe Medication Practices, Huntingdon Valley, PA, USA
    Arch Intern Med 164:1192-6. 2004
    ..When induced by benzocaine anesthetic spray and other chemicals, it can result in cyanosis and life-threatening complications...
  4. ncbi request reprint Reported medication errors associated with methotrexate
    Thomas J Moore
    Drug Safety and Policy, Institute for Safe Medication Practices, Huntingdon Valley, PA 19006, USA
    Am J Health Syst Pharm 61:1380-4. 2004
    ..Medication errors reported to FDA as adverse events in which methotrexate was identified as a possible contributor were studied...
  5. ncbi request reprint Serious adverse drug events reported to the Food and Drug Administration, 1998-2005
    Thomas J Moore
    Institute for Safe Medication Practices, 1800 Byberry Rd, Ste 810, Huntingdon Valley, PA 19006, USA
    Arch Intern Med 167:1752-9. 2007
    ..The US Food and Drug Administration has operated the Adverse Event Reporting System since 1998. It collects all voluntary reports of adverse drug events submitted directly to the agency or through drug manufacturers...
  6. pmc Prescription drugs associated with reports of violence towards others
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia, United States of America
    PLoS ONE 5:e15337. 2010
    ..Violence towards others is a seldom-studied adverse drug event and an atypical one because the risk of injury extends to others...
  7. doi request reprint Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008
    Thomas J Moore
    Institute for Safe Medication Practices, Alexandria, Virginia2Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services, Washington, DC
    JAMA Intern Med 174:90-5. 2014
    ....
  8. doi request reprint Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR)
    Thomas J Moore
    The Institute for Safe Medication Practices, Horsham, Pennsylvania, USA
    Semin Thromb Hemost 38:905-7. 2012
    ..3% for VTE associated with thalidomide. The incidence of these hematologic adverse drug events is high and reporting rates are low, and near the lower boundary of the 1 to 15% range seen for other events...
  9. pmc Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration
    Irving Kirsch
    Department of Psychology, University of Hull, Hull, United Kingdom
    PLoS Med 5:e45. 2008
    ..The purpose of this analysis is to establish the relation of baseline severity and antidepressant efficacy using a relevant dataset of published and unpublished clinical trials...
  10. ncbi request reprint Reported adverse drug events in infants and children under 2 years of age
    Thomas J Moore
    Center for Health Services Research and Policy, George Washington University School of Public Health and Health Services, Washington, DC 20006, USA
    Pediatrics 110:e53. 2002
    ..To characterize risks to infants and young children from drugs and biological products that were identified in spontaneous adverse event reports submitted to the US Food and Drug Administration...